Quantitative pharmacokinetic–pharmacodynamic modelling of baclofen‐mediated cardiovascular effects using BP and heart rate in rats

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|173|19|2845-2858

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.173, Iss.19, 2016-10, pp. : 2845-2858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose

By Mégarbane Bruno   Bloch Vanessa   Deye Nicolas   Baud Frédéric  

Intensive Care Medicine, Vol. 33, Iss. 1, 2007-01 ,pp. : 195-196

Springer Publishing Company

Access to resources Recommend Favorite

Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. S3, 2015-03 ,pp. : S51-S59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic‐pharmacodynamic modeling of omecamtiv mecarbil, a cardiac myosin activator, in healthy volunteers and patients with stable heart failure

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1236-1247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic‐pharmacodynamic modeling of omecamtiv mecarbil, a cardiac myosin activator, in healthy volunteers and patients with stable heart failure

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1236-1247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to Dr. Mégarbane et al. regarding “Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose”

By Isbister Geoffrey   Friberg Lena   Duffull Stephen  

Intensive Care Medicine, Vol. 33, Iss. 1, 2007-01 ,pp. : 197-197

Springer Publishing Company

Access to resources Recommend Favorite